Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.

Adiwijaya BS, Herrmann E, Hare B, Kieffer T, Lin C, Kwong AD, Garg V, Randle JC, Sarrazin C, Zeuzem S, Caron PR.

PLoS Comput Biol. 2010 Apr 15;6(4):e1000745. doi: 10.1371/journal.pcbi.1000745.

2.

Rapid decrease of wild-type hepatitis C virus on telaprevir treatment.

Adiwijaya BS, Hare B, Caron PR, Randle JC, Neumann AU, Reesink HW, Zeuzem S, Herrmann E.

Antivir Ther. 2009;14(4):591-5.

PMID:
19578245
4.

Introduction to chemical genomics.

Caron PR.

Methods Mol Biol. 2005;310:3-10. No abstract available.

PMID:
16350943
5.

CORES: an automated method for generating three-dimensional models of protein/ligand complexes.

Hare BJ, Walters WP, Caron PR, Bemis GW.

J Med Chem. 2004 Sep 9;47(19):4731-40.

PMID:
15341488
6.

Compendium of DNA topoisomerase sequences.

Caron PR.

Methods Mol Biol. 1999;94:279-316. No abstract available.

PMID:
12844883
7.

Genetic approach to chemical genetics.

Caron PR.

Drug Discov Today. 2002 Nov 15;7(22):1121. No abstract available.

PMID:
12546853
8.

A mutational analysis of the active site of human type II inosine 5'-monophosphate dehydrogenase.

Futer O, Sintchak MD, Caron PR, Nimmesgern E, DeCenzo MT, Livingston DJ, Raybuck SA.

Biochim Biophys Acta. 2002 Jan 31;1594(1):27-39.

PMID:
11825606
9.

Chemogenomic approaches to drug discovery.

Caron PR, Mullican MD, Mashal RD, Wilson KP, Su MS, Murcko MA.

Curr Opin Chem Biol. 2001 Aug;5(4):464-70. Review. No abstract available.

PMID:
11470611
10.

Crystal structure of JNK3: a kinase implicated in neuronal apoptosis.

Xie X, Gu Y, Fox T, Coll JT, Fleming MA, Markland W, Caron PR, Wilson KP, Su MS.

Structure. 1998 Aug 15;6(8):983-91.

11.

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding.

Kim JL, Morgenstern KA, Griffith JP, Dwyer MD, Thomson JA, Murcko MA, Lin C, Caron PR.

Structure. 1998 Jan 15;6(1):89-100.

12.

The structural basis for 14-3-3:phosphopeptide binding specificity.

Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC.

Cell. 1997 Dec 26;91(7):961-71.

14.

The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase.

Wilson KP, McCaffrey PG, Hsiao K, Pazhanisamy S, Galullo V, Bemis GW, Fitzgibbon MJ, Caron PR, Murcko MA, Su MS.

Chem Biol. 1997 Jun;4(6):423-31.

15.

Computer analysis of cloned sequences.

Caron PR.

Methods Mol Biol. 1997;69:247-60. No abstract available.

PMID:
9116857
16.

Crystal structure of p38 mitogen-activated protein kinase.

Wilson KP, Fitzgibbon MJ, Caron PR, Griffith JP, Chen W, McCaffrey PG, Chambers SP, Su MS.

J Biol Chem. 1996 Nov 1;271(44):27696-700.

17.

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET, Harbeson SL, Rice CM, Murcko MA, Caron PR, Thomson JA.

Cell. 1996 Oct 18;87(2):343-55. Erratum in: Cell 1997 Apr 4;89(1):159.

18.

Molecular dissection of a protein SopB essential for Escherichia coli F plasmid partition.

Hanai R, Liu R, Benedetti P, Caron PR, Lynch AS, Wang JC.

J Biol Chem. 1996 Jul 19;271(29):17469-75.

19.

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.

Sintchak MD, Fleming MA, Futer O, Raybuck SA, Chambers SP, Caron PR, Murcko MA, Wilson KP.

Cell. 1996 Jun 14;85(6):921-30.

20.

Human TOP3: a single-copy gene encoding DNA topoisomerase III.

Hanai R, Caron PR, Wang JC.

Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3653-7.

21.

Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32.

Lippke JA, Gu Y, Sarnecki C, Caron PR, Su MS.

J Biol Chem. 1996 Jan 26;271(4):1825-8.

22.

X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex.

Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon MJ, Fleming MA, Caron PR, Hsiao K, Navia MA.

Cell. 1995 Aug 11;82(3):507-22.

23.

Effects of yeast DNA topoisomerase III on telomere structure.

Kim RA, Caron PR, Wang JC.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2667-71.

24.

The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.

Caron PR, Watt P, Wang JC.

Mol Cell Biol. 1994 May;14(5):3197-207.

25.

Appendix. II: Alignment of primary sequences of DNA topoisomerases.

Caron PR, Wang JC.

Adv Pharmacol. 1994;29B:271-97. Review. No abstract available.

PMID:
8996613
26.

The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?

Wang JC, Caron PR, Kim RA.

Cell. 1990 Aug 10;62(3):403-6. No abstract available.

PMID:
2165864
27.
28.

Dynamics of the Escherichia coli nucleotide excision repair system.

Grossman L, Caron PR, Mazur SJ, Oh EY.

Ann Ist Super Sanita. 1989;25(1):75-9.

PMID:
2665605
29.

Potential role of proteolysis in the control of UvrABC incision.

Caron PR, Grossman L.

Nucleic Acids Res. 1988 Nov 25;16(22):10903-12.

30.
31.
32.

Potential role of proteolysis in the control of UvrABC incision.

Caron PR, Grossman L.

Nucleic Acids Res. 1988 Oct 25;16(20):9641-50. Corrected and republished in: Nucleic Acids Res. 1988 Nov 25;16(22):10903-12.

33.

Incision of damaged versus nondamaged DNA by the Escherichia coli UvrABC proteins.

Caron PR, Grossman L.

Nucleic Acids Res. 1988 Aug 25;16(16):7855-65.

34.

Repair of DNA-containing pyrimidine dimers.

Grossman L, Caron PR, Mazur SJ, Oh EY.

FASEB J. 1988 Aug;2(11):2696-701. Review.

PMID:
3294078
35.

The involvement of an E. coli multiprotein complex in the complete repair of UV-damaged DNA.

Grossman L, Caron PR, Oh EY.

Basic Life Sci. 1986;38:287-94.

PMID:
3527143
36.
37.

Supplemental Content

Loading ...
Support Center